Dr Joseph Fuhr: Interchangeability Poses Too Much Risk, Too Little Reward
Joseph P. Fuhr, Jr, PhD, professor emeritus, Widener University, discusses interchangability in biosimilars.
Dr Joseph Fuhr: Market Share Is Not the True Metric of Biosimilar Competition
Joseph P. Fuhr, Jr, PhD, professor emeritus, Widener University, discusses biosimilar competition and its effect on market share and price.
Dr Joseph Fuhr: Competition from Biosimilars Will Lead to Lower Prices Over Time
Joseph P. Fuhr, Jr, PhD, professor emeritus, Widener University, looks to evidence from Europe to predict US biosimilar cost-savings.
Dr Joseph Fuhr: The Immediate Economic Impact of Biosimilars May be Limited
Joseph P. Fuhr, Jr, PhD, professor emeritus, Widener University, sees a limited economic impact for biosimilars given current patent disputes.
Dr Joseph Fuhr: Biosimilar Competition Can Yield Consumer Savings
Joseph P. Fuhr, Jr, PhD, professor emeritus, Widener University, sees value in stakeholder education about biosimilar products.
